{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Amantadine to Treat Cognitive Dysfunction in Moderate to severe Traumatic Brain Injury
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To become familiar with a literature review designed to determine whether amantadine improves cognitive function posttraumatic brain injuries (TBI).Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the etiology, pathophysiology, and pharmacology related to traumatic brain injuries (TBIs).
- Recognize the methodology and results of the literature review.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$27.95
Credits:
- ANCC 3.0 CH
- DC - BON 3.0 CH
- KY-BON 3.0 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.--------------------------------------------------This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JTN0715A
Published: Jul/Aug 2015
Expires: 12/31/2026
Sources:
Journal of Trauma Nursing
Required Passing Score: 12/16 (75%)